Interims reflect the trading update earlier this month and the adverse impact from the DHSC dispute, which continues to rumble on despite agreement in principle being reached for the repayment of the outstanding debt. More encouragingly, there are meaningful signs of progress in developing a broader customer base, with two new MOUs announced today for the development and manufacture of a range of lateral flow tests across diverse indications. One of these builds on the relationship with Vatic, w ....
29 Mar 2022
Growing pipeline of opportunities
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Growing pipeline of opportunities
Abingdon Health PLC (ABDX:LON) | 9.2 0 (-5.1%) | Mkt Cap: 11.3m
- Published:
29 Mar 2022 -
Author:
Chris Glasper -
Pages:
3
Interims reflect the trading update earlier this month and the adverse impact from the DHSC dispute, which continues to rumble on despite agreement in principle being reached for the repayment of the outstanding debt. More encouragingly, there are meaningful signs of progress in developing a broader customer base, with two new MOUs announced today for the development and manufacture of a range of lateral flow tests across diverse indications. One of these builds on the relationship with Vatic, w ....